Abstract

IntroductionThe introduction of poly-ADP ribose polymerase inhibitors in ovarian cancer has demonstrated significantly improved progression free survival in four randomized controlled clinical trials in patients with platinum sensitive relapsed ovarian...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
U.A Matulonis ... B.J Monk
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 28
U.A Matulonis, et. al.U.A Matulonis ... B.J Monk
01 Mar 2017
Abstract 4676: DNA repair protein expression and response of homologous recombination deficient ovarian cancer to the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in the ARIEL2 Part 1 study
Andrea E Wahner Hendrickson ... Scott Kaufmann
American Journal of Cancer | VOL. 77
Andrea E Wahner Hendrickson, et. al.Andrea E Wahner Hendrickson ... Scott Kaufmann
01 Jul 2017
Abstract CT008: Phase I study of the alpha specific PI3-Kinase inhibitor BYL719 and the poly (ADP-Ribose) polymerase (PARP) inhibitor olaparib in recurrent ovarian and breast cancer: Analysis of the dose escalation and ovarian cancer expansion cohort
Panagiotis A Konstantinopoulos ...
American Journal of Cancer | VOL. 77
Panagiotis A Konstantinopoulos, et. al.Panagiotis A Konstantinopoulos ...
01 Jul 2017
OVARIO, A Phase 2 Study of Niraparib + Bevacizumab in Advanced Ovarian Cancer Following Front-Line Platinum-Based Chemotherapy with Bevacizumab: Updated Analysis (039)
Melissa Hardesty ... Debra Richardson
Gynecologic oncology | VOL. 166
Melissa Hardesty, et. al.Melissa Hardesty ... Debra Richardson
01 Aug 2022
View more papers

More From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Paper Title
Journal
Date
Author
Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer
Koji Matsuo ... Aiko Okamoto
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Koji Matsuo, et. al.Koji Matsuo ... Aiko Okamoto
06 Aug 2024
Hysterectomy with sentinel lymph node dissection in the setting of preoperative endometrial intraepithelial neoplasia and an endometrial stripe ≥20 mm: a cost-effectiveness analysis
Sarah Bell ... Jamie Lesnock
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Sarah Bell, et. al.Sarah Bell ... Jamie Lesnock
06 Aug 2024
Liver mobilization and sub-diaphragmatic peritonectomy by laparoscopy
Virginie Collin-Bund ... Chérif Akladios
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Virginie Collin-Bund, et. al.Virginie Collin-Bund ... Chérif Akladios
05 Aug 2024
Total pelvic exenteration with radical vulvectomy and anorectal resection in 10 steps
Elodie Gauroy ... Alejandra Martinez
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Elodie Gauroy, et. al.Elodie Gauroy ... Alejandra Martinez
05 Aug 2024
View more papers